Objective: Hereditary angioedema ( HAE) with normal C1 inhibitor (HAE-nC1-INH), is a genetically complex, rare disease and
mutations in F12, ANGPT1, PLG, MYOF genes are found in some families with HAE-nC1-INH. However, often a specific mutation
cannot be identified and this type is called as hereditary angioedema of unknown cause (U-HAE). Our aim was to identify putative
causative genetic alterations and/or pathways by whole exome sequencing in patients with U-HAE.
Patients and Methods: Nine patients from 8 families between the ages of 3 to 63 years with U-HAE and 6 controls were enrolled for
the study and whole exome sequencing were performed.
Results: No significant difference was found between the case and control group for the a priori suspected set of genes. Variants in the
genes; RAMP2, IL6, GP1BA, C1QBP were significantly different between U-HAE and control group. Downstream functional analysis
found that blood coagulation pathways were enriched in these genes.
Conclusion: Proteins that are not involved in contact pathways may also play a role in U-HAE. These variants need to be replicated in
larger cohorts and studied at the functional level to verify our findings.
Hereditary angioedema of unknown cause ( U-HAE) Whole exome sequencing (WES ) Genetic
Birincil Dil | İngilizce |
---|---|
Konular | Klinik Tıp Bilimleri |
Bölüm | Original Articles |
Yazarlar | |
Yayımlanma Tarihi | 27 Ekim 2021 |
Yayımlandığı Sayı | Yıl 2021 |